Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C8H14O2S2 |
| Molecular Weight | 206.326 |
| Optical Activity | ( + ) |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)CCCC[C@@H]1CCSS1
InChI
InChIKey=AGBQKNBQESQNJD-SSDOTTSWSA-N
InChI=1S/C8H14O2S2/c9-8(10)4-2-1-3-7-5-6-11-12-7/h7H,1-6H2,(H,9,10)/t7-/m1/s1
| Molecular Formula | C8H14O2S2 |
| Molecular Weight | 206.326 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
THIOCTIC ACID, also known as alpha-lipoic acid, is a vitamin-like antioxidant that acts as a free-radical scavenger. It exists in two enantiomeric forms, R and S, being the R isoform an essential cofactor of four mitochondrial enzyme complexes. THIOCTIC ACID is available as an over-the-counter nutritional supplement and has been used nutritionally and clinically since the 1950s for various diseases and conditions.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases. | 2014 |
|
| Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. | 2009-10 |
|
| Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. | 1997-03 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:50:40 GMT 2025
by
admin
on
Mon Mar 31 17:50:40 GMT 2025
|
| Record UNII |
VLL71EBS9Z
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DSLD |
2610 (Number of products:4)
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
30314
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
PRIMARY | |||
|
DTXSID20152651
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
PRIMARY | |||
|
11156
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
PRIMARY | |||
|
1200-22-2
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
PRIMARY | |||
|
CHEMBL134342
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
PRIMARY | |||
|
100000126090
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
PRIMARY | |||
|
16494
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
PRIMARY | |||
|
LIPOIC ACID
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
PRIMARY | |||
|
DB00166
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
PRIMARY | |||
|
SUB32811
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
PRIMARY | |||
|
CHEMBL33864
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
PRIMARY | |||
|
6112
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
PRIMARY | |||
|
VLL71EBS9Z
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
PRIMARY | |||
|
C171728
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
PRIMARY | |||
|
43796
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
PRIMARY | |||
|
VLL71EBS9Z
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
PRIMARY | |||
|
m10749
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
||
|
DERIVATIVE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
RACEMATE -> ENANTIOMER |
|
||
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
